Peter Hass

Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial

Ursula Nestle, Tanja Schimek‐Jasch, Stephanie Kremp et al. · The Lancet Oncology · 2020 · 177 citations

Medicine, Oncology, Radiation Oncology +14

Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases—A pooled analysis of the German working group “stereotactic radiotherapy”

Juliane Rieber, Jan Streblow, Lorenz Uhlmann et al. · Lung Cancer · 2016 · 161 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy

Matthias Gückenberger, Rainer J. Klement, Michael Allgäuer et al. · Radiotherapy and Oncology · 2015 · 126 citations · Full text

Medicine, Oncology, Radiation Oncology +16

The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases

Rainer J. Klement, N. Abbasi-Senger, Sonja Adebahr et al. · BMC Cancer · 2019 · 97 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Prospective Randomized Trial of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid for Prevention of Radiation-Induced Liver Toxicity

Max Seidensticker, Ricarda Seidensticker, Robert Damm et al. · PLoS ONE · 2014 · 65 citations · Full text

Medicine, Oncology, Pharmacology +17